Feasibility Study of the FARAPULSE™ Cardiac Ablation System Plus in the Treatment of Persistent Atrial Fibrillation(PersAFOne II)

NCT05152966 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Boston Scientific Corporation